A space for sharing and discussing news related to global current events, technology, and society.
69464 Members
We'll be adding more communities soon!
© 2020 Relevant Protocols Inc.
A space for sharing and discussing news related to global current events, technology, and society.
69464 Members
We'll be adding more communities soon!
© 2020 Relevant Protocols Inc.
Relevant
Hot
New
Spam
Relevant
Hot
New
Spam
0
209
0
209
>"Molnupiravir’s approval comes a day after the FDA cleared a more effective competing antiviral pill from Pfizer."
>"Molnupiravir’s approval comes a day after the FDA cleared a more effective competing antiviral pill from Pfizer."
>"Molnupiravir’s approval comes a day after the FDA cleared a more effective competing antiviral pill from Pfizer."
>"Molnupiravir’s approval comes a day after the FDA cleared a more effective competing antiviral pill from Pfizer."
Some low-ranking comments may have been hidden.
Some low-ranking comments may have been hidden.